Apogee Therapeutics (APGE) Stock Forecast, Price Target & Predictions

APGE Stock Forecast

Apogee Therapeutics stock forecast is as follows: an average price target of $95.00 (represents a 104.21% upside from APGE’s last price of $46.52) and

APGE Price Target

Apogee Therapeutics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 13, 2024	Alex Thompson	Stifel Nicolaus	$95.00	$52.71	80.23%	104.21%

Row per page

Go to

The latest Apogee Therapeutics stock forecast, released on May 13, 2024 by Alex Thompson from Stifel Nicolaus, set a price target of $95.00, which represents a 80.23% increase from the stock price at the time of the forecast ($52.71), and a 104.21% increase from APGE last price ($46.52).

Apogee Therapeutics Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$95.00
Last Closing Price	$46.52	$46.52	$46.52
Upside/Downside	-100.00%	-100.00%	104.21%

In the current month, the average price target of Apogee Therapeutics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Apogee Therapeutics's last price of $46.52. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Apogee Therapeutics Financial Forecast

Apogee Therapeutics Revenue Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Apogee Therapeutics's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. APGE's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Apogee Therapeutics EBITDA Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict APGE's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Apogee Therapeutics's previous annual EBITDA (undefined) of $NaN.

Apogee Therapeutics Net Income Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-63.33M	$-63.53M	$-60.95M	$-59.28M	$-58.11M	$-56.97M	$-55.85M	$-54.75M	$-60.35M	$-52.90M	$-56.12M	$-48.97M	$-60.38M	$-49.92M	$-33.81M
High Forecast	$-63.33M	$-63.53M	$-60.95M	$-59.28M	$-58.11M	$-56.97M	$-55.85M	$-54.75M	$-60.35M	$-52.90M	$-56.12M	$-48.97M	$-58.53M	$-49.92M	$-33.81M
Low Forecast	$-63.33M	$-63.53M	$-60.95M	$-59.28M	$-58.11M	$-56.97M	$-55.85M	$-54.75M	$-60.35M	$-52.90M	$-56.12M	$-48.97M	$-61.61M	$-49.92M	$-33.81M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Apogee Therapeutics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. APGE's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Apogee Therapeutics SG&A Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Apogee Therapeutics's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to APGE last annual SG&A of $NaN (undefined).

Apogee Therapeutics EPS Forecast

	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-1.12	$-1.12	$-1.07	$-1.04	$-1.02	$-1.00	$-0.98	$-0.96	$-1.06	$-0.93	$-0.99	$-0.86	$-1.06	$-0.88	$-0.60
High Forecast	$-1.12	$-1.12	$-1.07	$-1.04	$-1.02	$-1.00	$-0.98	$-0.96	$-1.06	$-0.93	$-0.99	$-0.86	$-1.03	$-0.88	$-0.60
Low Forecast	$-1.12	$-1.12	$-1.07	$-1.04	$-1.02	$-1.00	$-0.98	$-0.96	$-1.06	$-0.93	$-0.99	$-0.86	$-1.08	$-0.88	$-0.60
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Apogee Therapeutics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to APGE previous annual EPS of $NaN (undefined).

APGE Forecast FAQ

Will Apogee Therapeutics stock go up soon?

According to Wall Street analysts' prediction for APGE stock, the company can go up by 104.21% (from the last price of $46.52 to the average price target of $95), up by 104.21% based on the highest stock price target, and up by 104.21% based on the lowest stock price target.

Can Apogee Therapeutics stock reach $70?

APGE's average twelve months analyst stock price target of $95 supports the claim that Apogee Therapeutics can reach $70 in the near future.